LBS Submission rules & guidelines

The ESC currently does not allow late-breaking research submissions exclusively from Institutions in the Russian Federation and/or Belarus.
However collaborative research may be submitted and (if accepted) presented by co-authors from other countries.

PART 1 - SUBMISSION GUIDELINES

The deadline for LBS submissions is Thursday 2 April 2026, 12:00 noon CEST.

There will be no extension.

Submissions are only possible through the online submission services.

Changes and corrections

Once submitted, it will not be possible to make any corrections to the content or other information (such as presenter details, topic, etc.). In order to correct your submission, you must withdraw it and submit a new version prior to the deadline (see below for withdrawal procedure). Note that such a replacement of your submission is not possible after the submission deadline.

Withdrawal

If you want to withdraw a Late-Breaking Research already submitted, please notify us as quickly as possible at acnap-congressscientific@escardio.org stating the title and number to be withdrawn.

Note that withdrawal is still possible after the submission deadline.

In order to submit, you must complete the following five steps -

Step 1 - General information

Study details

Topic - Select one topic from the list of topics shown to index your research.

Full Title of study - A maximum of 200 characters typed in lower-case letters, except for abbreviations and study names. Please be aware that your title might be truncated if you copy and paste it into the field.

Acronym - If the study to be presented is known through an acronym, please indicate the name of the study (e.g. "EMIT") in this field as well as the full name of the acronym (e.g. "European Mizaverol Trial").

Short title for programme - Enter a short title for ACNAP programme (Scientific programme/ESC 365….). Indicate the acronym followed by a short title for your trial. This title will be used as presentation title if accepted.

Funding Acknowledgements - All sources of financial support (including governmental grants) for this research should be listed under this heading. All grant funding agency abbreviations should be spelled out.

Study confidentiality and embargo requirements

Data previously submitted as an abstract to ACNAP 2026 -

If you have already submitted an abstract (during the Call for abstracts) on this study, indicate the abstract number.

If your study is accepted as a late-breaking submission, you will be asked to withdraw your earlier abstract submission.

Submitted Late-Breaking Research should not have been published in any journals and/or online publications nor presented at any congresses. This embargo applies until presentation at ACNAP 2026.

Nevertheless, simultaneous publication is authorised.

If you have already submitted or intend to submit your data/results for simultaneous publication, indicate the name of the journal/publication.

Publication information - Journal Publication information is required – specify whether the data have been submitted or will be submitted for simultaneous publication.

Although the data may be submitted to a journal for consideration, it may not be published before the date of the presentation at ACNAP 2026. The embargo must remain in place until the scheduled start time of the presentation or publication of the Press release by ESC.

Step 2 - Author information and Author list

Your submission must list at least 1 author in order to be completed.

Author list

Enter each author and affiliation. The presenter must be included in the author list and positioned as First author.

You can enter up to 15 authors.

NB: The submitter certifies that he/she has permission from all persons he/she enters as co-authors to be listed.

If none of the authors is available to present during the congress, the application must be withdrawn.

Step 3 - Research content

All abstracts must be submitted in English with accurate grammar and spelling suitable for publication.

Abstracts submitted on animal studies: Study must follow the "Principles of laboratory animal care" (NIH Publication no. 85-23 revised 1985) and be in agreement with the national law if applicable.

Please note that any medical research involving human subjects must conform to the principles of the Declaration of Helsinki of the World Medical Association and must have been approved by an IRB.

Do not cut and paste symbols into your text.

Technical information for content -

Size - The maximum abstract size is 3750 characters.

The character limit does not include the title, nor the authors and the image (if any). Only the abstract text and spaces are taken into account.

Picture(s) - In addition to your text, you can add 1 picture.
Should you wish to insert a table in your submission, you need to upload it as a picture.
Your picture file(s) must meet the following criteria:
Format: JPEG
Size: less than 2 MB
Measures no larger than 1920 pixels(x) x 1080 pixels(y)

Submitters are responsible for the pictures uploaded – Please make sure that your picture(s) is(are) correctly uploaded and readable. It is the responsibility of the submitter to ensure the quality of the attachment(s) is suitable.

PART 2 - SUBMISSION RULES

Submissions

There is no limit to the number of Late-Breaking Research applications an author may submit, but you should not submit the same research twice, even under a different topic.

If you submit two applications with the same title, content, the submission service will automatically keep the most recent one and withdraw the other.

Embargo and Publication

All scientific presentations at an ESC event, including unpublished results presented in “Late- Breaking Research” sessions; and other session types are embargoed until the scheduled start time of the presentation or the publication of a press release by the ESC.

Lead authors are responsible for notifying all authors and other relevant stakeholders - including sponsors - about the Policy.

It is essential that you are fully aware of the ESC Media and Embargo Policy and comply with the terms when submitting your application – access terms here - /The-ESC/Press-Office/ESC-Media-and-Embargo-Policy

Policies

Submission of an application constitutes a commitment by the author(s) to present the work in-person in Sophia-Antipolis, if accepted. Failure to present, upload and register for the Congress by the set deadlines will lead to the withdrawal of the research from the scientific programme.

All expenses (registration, airfare, hotel…..) associated with the submission and presentation of the research are under the responsibility of the presenter.
In case of exceptional circumstances or events, ESC reserves the right to modify presentation terms and conditions and will notify presenters accordingly.

Affirmation of originality and copyright transfer of statement

The submitter hereby affirms that the work submitted is original, except for extracts from copyrighted works fully authorised by the copyright holders, and that all statements declared as facts are based on thorough examination and investigation for accurateness.

By submitting your work to the ESC, you consent to have authors’ names, affiliation and biographical material being used in connection with the publication of your work.

Author(s) represents and warrants that he/she/they is/are sole author(s) of the work, that all authors have participated in and agree with the content and conclusions of the work, and that the work is original and does not infringe upon any copyright, proprietary, or personal right of any third party.

Submitting/Presenting published or already presented work will jeopardize future acceptance.

Author(s) retains the right, after presentation at the Congress, to subsequently include the work in articles, books, or derivative works that he/she authors, or edits provided said use does not imply the endorsement of the ESC.

The submitter signs for all co-authors and accepts responsibility on the present rules for submission and presentation for transferring copyright on behalf of all co-authors.

For accepted submissions, ESC Press team will have access to this submitted abstract to write the Press Release, which you will be asked to review prior to finalisation.

ESC reserves the right to provide its press releases a few days before public release to a selected list of Journalists who have previously agreed in writing to respect the ESC embargo policy.

The content belongs to the author(s). However if the study is accepted for presentation, the presenter can agree, on behalf of all co-authors, to transfer and assign to the ESC free of charge, on a non-exclusive basis, for twenty years the rights to edit, publish, reproduce, distribute copies and prepare derivative works such as press release and/or educational products, using all communication tools and means, now known or hereinafter developed, including any and all digital means and any and all supports or forms of media, now known or hereinafter developed, in particular all paper, analog, digital, numerical and electronic media, including Internet, Intranet and Extranet sites and social media. This includes use in indexes or search databases in print, electronic, or other media.

Conflict of interest

The Congress Programme Committee requests all presenters to disclose their potential conflict(s) of interest at the time of acceptance of presentation (agreement form submission).

It is also the responsibility of the presenter to disclose any potential conflict(s) of interest from co-authors pertaining to the presentation on the presentation itself (as may be required).

This will allow the audience to take potential conflicts of interest into account when assessing the objectivity of the presentation.
A potential conflict of interest may arise from various relationships, past or present, such as employment, consultancy, investments and stock ownership, funding for research, family relationship, etc.

All potential conflicts of interest must be stated.

This pertains to relationships with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the subject matter of the article. Such relationships include, but are not limited to, employment by an industrial concern, ownership of stock, membership on a standing advisory council or committee, being on the board of directors, or being publicly associated with the company or its products. Other areas of real or perceived conflict of interest could include receiving honoraria or consulting fees or receiving grants or funds from such corporations or individuals representing such corporations.

Data Privacy

By certifying that you have read these Submission rules, you also confirm having received the prior approval from the co-authors to provide their data to the ESC.

The information collected in this CALL FOR LATE-BREAKING RESEARCH is subject to data processing to proceed with the elaboration of ACNAP 2026 scientific programme.

Provision of personal data is a statutory requirement to list the authors who have contributed to the research submitted.

The recipients of the data are ESC Staff who process the submissions and the ESC Committees and volunteers involved in the scientific programme.

Data collected will be kept for 20 years.

Transfer of personal data to ESC Staff, contractors as well as other ESC related scientific organisations occurs for production, promotion and dissemination of the Congress Content.

In accordance with the chapter 3 of the European Regulation 2016/679 with regards to data protection, you have the right to request from ESC, access to and rectification or erasure of your personal data or restriction of processing concerning your data or to object to processing as well as the right to data portability. This is done thru withdrawal of the submission according to the terms and conditions of withdrawal.

For data privacy concerns, please contact (kindly note that a proof of identity will be required during the process through a secured link) - Data Privacy

European Society of Cardiology

Les Templiers

2035 Route des Colles

CS 80179 Biot

06903 SOPHIA ANTIPOLIS CEDEX, France

Or by email to dataprivacy@escardio.org

You have the right to lodge a complaint with a supervisory authority, and for information, ESC has appointed a Data Protection Officer that you can reach at dpo@escardio.org

Applicable law

All the rules pertaining to the present submission are governed by, and construed in accordance with the laws of France without regard to any conflicts of laws principles thereof that would require the application of the law of any other jurisdiction. Any disputes arising in relation hereto shall be submitted to the exclusive jurisdiction of the French Tribunal Judiciaire located in Grasse, France.

The ESC reserves the right to make changes to the Late-Breaking Research submission rules based on the Covid-19 situation and convention centre restrictions/protocols/requirements; and/or in case of exceptional/Force Majeure events (defined as unforeseeable and irresistible events beyond control of the ESC, such as natural disasters, war, civil unrest, coup d'Etat….).

Any update or change will be posted on the ESC website.

If you have difficulties in submitting or if you need any further information, please contact us at acnap-congressscientific@escardio.org

PART 3 - INFORMATION ON SELECTION AND RESULTS - PRESENTATION RULES

Results -

After the submission deadline, the system will be closed, and submissions will be sent to the Reviewing Committee. Changes or corrections will not be possible after the deadline.

The final selection will be made by the Selection Committee, that will determine the appropriate presentation format, day and time of presentation. No rescheduling or changes will be possible.

Results announcement -

An email message will be sent to all submitters by mid-April 2026 with a report on the status of their submission (accepted or rejected).

If the Late-Breaking Research is accepted, notification and further instructions concerning the presentation format will be sent directly to the assigned presenter (as indicated in the submission form).

If your submission is accepted in a Late-Breaking Research session, you are required to immediately withdraw any other type of submission of the same research.

INFORMATION FOR THE PRESENTER

The presenter will be asked to submit an agreement form online before the given deadline.

We remind you that the Lead authors are responsible for notifying all authors and other relevant stakeholders - including sponsors - about the ESC Media and Embargo Policy.

If contacted by other organisations for interviews, articles, etc …, the presenter must ascertain adherence to the embargo policy before providing any information to third parties.

Late-Breaking Research submission rules and guidelines

ACNAP 2026, Sophia-Antipolis, France, 12 - 13 June